Sonoma Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

11. Significant Customer Concentrations

11. Significant Customer Concentrations	9 Months Ended
Dec. 31, 2016
Risks and Uncertainties [Abstract]
Significant Customer Concentrations	For the three months ended December 31, 2016, one customer represented 22%, one customer represented 16%, one customer represented 13% and one customer represented 10% of net revenue. For the three months ended December 31, 2015, one customer represented 33% and one customer represented 10% of net revenue. For the nine months ended December 31, 2016, one customer represented 27% of net revenue. For the nine months ended December 31, 2015, one customer represented 35% of net revenue. At December 31, 2016, one customer represented 30%, one customer represented 26%, one customer represented 23%, one customer represented 16% and one customer represented 13% of the net accounts receivable balance. At March 31, 2016, one customer represented 33% of the net accounts receivable balance.

11. Significant Customer Concentrations

9 Months Ended

Dec. 31, 2016

For the three months ended December 31, 2016, one customer represented 22%, one customer represented 16%, one customer represented 13% and one customer represented 10% of net revenue. For the three months ended December 31, 2015, one customer represented 33% and one customer represented 10% of net revenue.

For the nine months ended December 31, 2016, one customer represented 27% of net revenue. For the nine months ended December 31, 2015, one customer represented 35% of net revenue.

At December 31, 2016, one customer represented 30%, one customer represented 26%, one customer represented 23%, one customer represented 16% and one customer represented 13% of the net accounts receivable balance. At March 31, 2016, one customer represented 33% of the net accounts receivable balance.